Ms Siobhán McArdle:

Part of the work we will be doing in 2024 is an evaluation of our current national drugs strategy, taking on board the learning from our EU partners. It is that piece around looking at how we are doing against what we said we would do and looking at how we are doing against the European model using European data where available.